{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Wilson",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA021549"
        ],
        "brand_name": [
          "EMEND"
        ],
        "generic_name": [
          "APREPITANT"
        ],
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "product_ndc": [
          "0006-0461",
          "0006-0462",
          "0006-3862",
          "0006-0464",
          "0006-3066"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "APREPITANT"
        ],
        "rxcui": [
          "403810",
          "403811",
          "404465",
          "404466",
          "644088",
          "644278",
          "754508",
          "754509",
          "1729308",
          "1729311"
        ],
        "spl_id": [
          "428f7828-6d1c-438b-a17d-b4af0700c740"
        ],
        "spl_set_id": [
          "696f9e80-9cae-403b-de9e-078343ce4713"
        ],
        "package_ndc": [
          "0006-0461-02",
          "0006-0461-01",
          "0006-0461-06",
          "0006-0461-12",
          "0006-0462-01",
          "0006-0462-06",
          "0006-3862-03",
          "0006-3862-13",
          "0006-0464-01",
          "0006-0464-10",
          "0006-0464-05",
          "0006-3066-01",
          "0006-3066-03"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185507",
          "N0000185506"
        ],
        "pharm_class_moa": [
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "1NF15YR6UY"
        ]
      },
      "product_type": "Drugs",
      "event_id": "98113",
      "recalling_firm": "Merck Sharp & Dohme LLC",
      "address_1": "4633 Merck Rd W",
      "address_2": "N/A",
      "postal_code": "27893-9613",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0241-2026",
      "product_description": "Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by:  Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03",
      "product_quantity": "3 - single dose kits",
      "reason_for_recall": "Presence of particulate matter: potential presence of metal particulates in the product.",
      "recall_initiation_date": "20251212",
      "center_classification_date": "20251223",
      "report_date": "20251231",
      "code_info": "Lot #: Z014503, Exp 11/15/2027"
    }
  ]
}